ABBOTT LABORATORIES — Director's Dealing 2004

Nov 12, 2004

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-11-09

Reporting Person: NEMMERS JOSEPH M (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2004-11-09	Common Shares without par value	M	6197	$20.5347	Acquired	65653	Direct
2004-11-09	Common Shares without par value	M	4715	$33.2314	Acquired	70368	Direct
2004-11-09	Common Shares without par value	F	6801	$44.96	Disposed	63567	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2004-11-09	Option (right to buy)	$20.5347	M	6197	Disposed	2006-02-08	Common Shares (6197)	Direct
2004-11-09	Option (right to buy)	$33.2314	M	4715	Disposed	2013-02-13	Common Shares (4715)	Direct
2004-11-09	Option (right to buy)	$44.96	A	2830	Acquired	2006-02-08	Common Shares (2830)	Direct
2004-11-09	Option (right to buy)	$44.96	A	3971	Acquired	2013-02-13	Common Shares (3971)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares without par value	10521	Indirect
Common Shares without par value	336	Indirect
Common Shares without par value	336	Indirect
Common Shares without par value	276	Indirect
Common Shares without par value	282	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of November 9, 2004.

F2: Reporting person disclaims beneficial ownership of all securities held by his sons.

F3: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.

F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.